These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 8187070
1. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Davis RJ, D'Cruz CM, Lovell MA, Biegel JA, Barr FG. Cancer Res; 1994 Jun 01; 54(11):2869-72. PubMed ID: 8187070 [Abstract] [Full Text] [Related]
2. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue. Chen BF, Chen ML, Liang DC, Huang YW, Liu HC, Chen SH. Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb 01; 62(2):86-91. PubMed ID: 10063718 [Abstract] [Full Text] [Related]
3. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Barr FG, Nauta LE, Davis RJ, Schäfer BW, Nycum LM, Biegel JA. Hum Mol Genet; 1996 Jan 01; 5(1):15-21. PubMed ID: 8789435 [Abstract] [Full Text] [Related]
4. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Davis RJ, Barr FG. Proc Natl Acad Sci U S A; 1997 Jul 22; 94(15):8047-51. PubMed ID: 9223312 [Abstract] [Full Text] [Related]
5. Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14). Frascella E, Lenzini E, Schafer BW, Brecevic L, Dorigo E, Toffolatti L, Nanni P, De Giovanni C, Rosolen A. Cancer Genet Cytogenet; 2000 Sep 22; 121(2):139-45. PubMed ID: 11063797 [Abstract] [Full Text] [Related]
15. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator. Sublett JE, Jeon IS, Shapiro DN. Oncogene; 1995 Aug 03; 11(3):545-52. PubMed ID: 7630639 [Abstract] [Full Text] [Related]
16. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher FJ, Emanuel BS, Rovera G, Barr FG. Nat Genet; 1993 Nov 03; 5(3):230-5. PubMed ID: 8275086 [Abstract] [Full Text] [Related]
17. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. Collins MH, Zhao H, Womer RB, Barr FG. Med Pediatr Oncol; 2001 Aug 03; 37(2):83-9. PubMed ID: 11496344 [Abstract] [Full Text] [Related]
18. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG. J Clin Oncol; 2002 Jun 01; 20(11):2672-9. PubMed ID: 12039929 [Abstract] [Full Text] [Related]
19. Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions. Barr FG, Qualman SJ, Macris MH, Melnyk N, Lawlor ER, Strzelecki DM, Triche TJ, Bridge JA, Sorensen PH. Cancer Res; 2002 Aug 15; 62(16):4704-10. PubMed ID: 12183429 [Abstract] [Full Text] [Related]